BCL2 and CASP8 regulation by NF‐κB differentially affect mitochondrial function and cell fate in antiestrogen‐sensitive and ‐resistant breast cancer cells-Reference-Cited by-同舟云学术

BCL2 and CASP8 regulation by NF‐κB differentially affect mitochondrial function and cell fate in antiestrogen‐sensitive and ‐resistant breast cancer cells

Published:2010-02-12 Issue:6 Volume:24 Page:2040-2055
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Nehra Ruchi¹,Riggins Rebecca B.¹,Shajahan Ayesha N.¹,Zwart Alan¹,Crawford Anatasha C.¹,Clarke Robert¹

Affiliation:

1. Department of Oncology Georgetown University School of Medicine Washington DC USA

Funder

Medical Research and Materiel Command

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.09-138305

Reference52 articles.

1. Cellular and molecular pharmacology of antiestrogen action and resistance;Clarke R.;Pharmacol. Rev.,2001

2. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling

3. Cancer Statistics, 2008

4. Antiestrogens, Aromatase Inhibitors, and Apoptosis in Breast Cancer

5. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor–Positive Breast Cancer;Cancer Research;2023-07-14

2. In Vitro Anticancer Activity of Methanolic Extract of Justicia adhatoda Leaves with Special Emphasis on Human Breast Cancer Cell Line;Molecules;2022-11-25

3. Exploring new pathways in endocrine-resistant breast cancer;Exploration of Targeted Anti-tumor Therapy;2022-06-20

4. Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance;Cells;2022-05-18

5. Advantages and drawbacks of dexamethasone in glioblastoma multiforme;Critical Reviews in Oncology/Hematology;2022-04